Deficiencies of calcium-regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Ketteler, Markus ^a   Wanner, Christoph ^b   Metzger, Thomas ^b   Bongartz, Philipp ^b   Westenfeld, Ralf ^b   Gladziwa, Ulrich ^b   Schurgers, Leon J ^b   Vermeer, Cees ^b   Jahnen Dechent, Willi ^b   Floege, Jürgen ^b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b NONE

Author keywords

AHSG Fetuin; Calcium regulatory proteins; Cardiovascular calcification; MGP; Uremia

Indexed keywords

ALPHA2 HEREMANS SCHMID GLYCOPROTEIN; CALCIUM PHOSPHATE; OSTEOCALCIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG; CALCIUM; CALCIUM BINDING PROTEIN; MATRIX GLA PROTEIN; SCLEROPROTEIN;

BLOOD VESSEL CALCIFICATION; CALCIUM BLOOD LEVEL; CONFERENCE PAPER; CORONARY ARTERY DISEASE; DIALYSIS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERPHOSPHATEMIA; HYPERTENSION; KNOCKOUT MOUSE; MORTALITY; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; UREMIA; ANIMAL; CALCINOSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; METABOLISM; PATHOLOGY; RENAL REPLACEMENT THERAPY; REVIEW;

ANIMALS; CALCINOSIS; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIOVASCULAR DISEASES; EXTRACELLULAR MATRIX PROTEINS; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS; UREMIA;

EID: 1842513889     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.21.x     Document Type: Conference Paper

References (25)

1. US RENAL DATA SYSTEM. USRDS 1998 Annual Data Report, Bethesda, MD: National Institute of Diabetes and Kidney Diseases, 1999:63-90.
2. VALDERRABANO F, BERTHOUX FC, JONES EH, MEHLS O: Report on management of renal failure in Europe, XXV, 1994 end stage renal disease and dialysis report. The EDTA-ERA Association. Nephrol Dial Transplant 11(Suppl 1):2-21, 1996
3. DAVIES MR, HRUSKA KA: Pathophysiological mechanisms of vascular calcification in end-stage renal disease. Kidney Int 60:472-479, 2001
4. COZZOLINO M, DUSSO AS, SLATOPOLSKY E: Role of calcium-phosphate product and bone-associated proteins on vascular calcification in renal failure. J Am Soc Nephrol 12:2511-2516, 2001
5. BLOCK GA, PORT FK: Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 35:1226-1237, 2000
6. BLOCK GA, HULBERT-SHEARON TE, LEVIN NW, et al: Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 31:607-617, 1998
7. GANESH SK, STACK AG, LEVIN NW, et al: Association of elevated serum PO(4), Ca x PO(4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138, 2001
8. GOODMAN WG, GOLDIN J, KUIZON BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483, 2000
9. TINTUT Y, DEMER LL: Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 12:555-560, 2001
10. DHORE CR, CLEUTJENS JPM, LUTGENS E, et al: Differential expression of bone matrix regulatory proteins in human atherosclerotic plaques. Arterioscler Thromb Vasc Biol 21:1998-2003, 2001
11. SHANAHAN CM, CARY NR, METCALFE JC, et al: High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. J Clin Invest 93:2393-2402, 1994
12. LUO G, DUCY P, MCKEE MD, et al: Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 386:78-81, 1997
13. SCHINKE T, AMENDT C, TRINDL A, et al: The serum protein alpha2-HS glycoprotein/fetuin inhibits apatite formation in vitro and in mineralizing calvaria cells. A possible role in mineralization and calcium homeostasis. J Biol Chem 271:20789-20796, 1996
14. JAHNEN-DECHENT W, SCHINKE T, TRINDL A, et al: Cloning and targeted deletion of the mouse fetuin gene. J Biol Chem 272:31496-31503, 1997
15. PRICE PA THOMAS GR, PARDINI AW, et al: Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix Gla protein in the serum of etidronate-treated rats. J Biol Chem 277:3926-3934, 2002
16. 2HS glycoprotein is a negative acute-phase reactant. J Clin Invest 64:1118-1129, 1979
17. ZIMMERMANN J, HERRLINGER S, PRUY A, et al: Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int 55:648-658, 1999
18. RIDKER PM, RIFAI N, CLEARFIELD M, et al: Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events N Engl J Med 344:1959-1965, 2001
19. SCHURGERS LJ, DISSEL PEP, SPRONK HMH, et al: Role of vitamin K and vitamin K-dependent proteins in vascular calcification. Z Kardiol 90(Suppl 3):57-63, 2001
20. BINKERT C, DEMETRIOU M, SUKHU B, et al: Regulation of osteogenesis by fetuin. J Biol Chem 274:28514-28520, 1999
21. MATHEWS ST, SINGH GP, RANALLETTA M, et al: Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51:2450-2458, 2002
22. FARZANEH-FAR A, BRAAM LAJLM, SPRONK HMH, et al: Promotor polymorphisms of the human matrix Gla protein promotor and serum concentrations. J Biol Chem 276:32466-32473, 2001
23. HERMANN S-M, WHATLING C, BRAND E, et al: Polymorphism of the human matrix Gla protein (MGP) gene, vascular calcification, and myocardial infarction. Arterioscler Thromb Vasc Biol 20:2386-2393, 2000
24. BRAAM LAJLM, DISSEL PE, GIJSBERS BLMG, et al: Assay for human matrix Gla-protein in serum: Potential applications in the cardiovascular field. Arterioscl Thromb Vasc Biol 20:1257-1261, 2000
25. KETTLER M, BOGARTZ P, WESTENFELD R, et al: Association of low fetuin (AHSG) concentrations in serum with cardiovascular mortality in patients and dialysis: a cross-sectional study. Lancet 361:827-833, 2003